Integrated study: Phase 3 PEACHTREE, AZALEA indicate significant BCVA gains, CST reduction

The Phase 3 integrated PEACHTREE and AZALEA study data revealed strong safety and efficacy for triamcinolone acetonide via suprachoirodal injection.

Advancing IOL technology for treatment of presbyopia

Ora's Caitlin Black, senior director and therapeutic area head of medical devices, talks about the next generation of ophthalmic device therapies and diagnostics, clinical trial updates and new innovations that are most exciting for presbyopia treatment.

Weekly review in ophthalmology: 14 May - 20 May

An end-of-week review of what happened in ophthalmology from 14 May to 20 May.